EE9900012A - Uudsed ühendid - Google Patents

Uudsed ühendid

Info

Publication number
EE9900012A
EE9900012A EEP199900012A EE9900012A EE9900012A EE 9900012 A EE9900012 A EE 9900012A EE P199900012 A EEP199900012 A EE P199900012A EE 9900012 A EE9900012 A EE 9900012A EE 9900012 A EE9900012 A EE 9900012A
Authority
EE
Estonia
Prior art keywords
novel compounds
novel
compounds
Prior art date
Application number
EEP199900012A
Other languages
English (en)
Inventor
Bantick John
Perry Matthew
Thorne Philip
Original Assignee
Astra Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614360.7A external-priority patent/GB9614360D0/en
Priority claimed from GBGB9626884.2A external-priority patent/GB9626884D0/en
Application filed by Astra Pharmaceuticals Limited filed Critical Astra Pharmaceuticals Limited
Publication of EE9900012A publication Critical patent/EE9900012A/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
EEP199900012A 1996-07-09 1997-07-04 Uudsed ühendid EE9900012A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9614360.7A GB9614360D0 (en) 1996-07-09 1996-07-09 Compounds
GBGB9626884.2A GB9626884D0 (en) 1996-12-24 1996-12-24 Compounds
PCT/SE1997/001219 WO1998001449A1 (en) 1996-07-09 1997-07-04 Novel compounds

Publications (1)

Publication Number Publication Date
EE9900012A true EE9900012A (et) 1999-06-15

Family

ID=26309668

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900012A EE9900012A (et) 1996-07-09 1997-07-04 Uudsed ühendid

Country Status (16)

Country Link
EP (1) EP0915879A1 (et)
JP (1) JP2000516206A (et)
KR (1) KR20000023644A (et)
AR (1) AR008395A1 (et)
AU (1) AU708882B2 (et)
BR (1) BR9710215A (et)
CA (1) CA2260057A1 (et)
CZ (1) CZ3699A3 (et)
EE (1) EE9900012A (et)
ID (1) ID18889A (et)
IL (1) IL127690A0 (et)
IS (1) IS4932A (et)
NO (1) NO990072D0 (et)
PL (1) PL331090A1 (et)
TR (1) TR199900013T2 (et)
WO (1) WO1998001449A1 (et)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100922538B1 (ko) 2001-08-13 2009-10-21 얀센 파마슈티카 엔.브이. 2,4,5-삼치환된 티아졸릴 유도체 및 그의 항염증성 활성
WO2011063927A1 (en) * 2009-11-24 2011-06-03 Novaled Ag Organic electronic device comprising an organic semiconducting material
JP6067873B2 (ja) * 2012-11-30 2017-01-25 エルジー・ケム・リミテッド 新規な化合物およびそれを用いた有機電子素子
KR102153040B1 (ko) 2013-11-28 2020-09-07 삼성전자주식회사 축합환 화합물 및 이를 포함한 유기 발광 소자
CN108484606B (zh) * 2018-03-16 2020-03-06 江南大学 一种嘧啶并[4,5-f]喹唑啉类化合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670577A1 (de) * 1967-10-05 1971-05-19 Akad Wissenschaften Ddr Verfahren zur Herstellung von 5-oxo-5.6.7.8-tetrahydro-chinazelinen
US4272535A (en) * 1978-07-31 1981-06-09 Schering Corporation 2,4-[1H,3H,5H]-(1)-Benzopyrano-[2,3-d]-pyrimidinediones and their use as anti-allergy agents
US4762843A (en) * 1986-09-15 1988-08-09 Warner-Lambert Company Hetero [f] fused carbocyclic pyridines as dopaminergic agents
US5597823A (en) * 1995-01-27 1997-01-28 Abbott Laboratories Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists

Also Published As

Publication number Publication date
NO990072D0 (no) 1999-01-08
AU3711697A (en) 1998-02-02
ID18889A (id) 1998-05-20
IL127690A0 (en) 1999-10-28
BR9710215A (pt) 1999-08-10
EP0915879A1 (en) 1999-05-19
JP2000516206A (ja) 2000-12-05
CZ3699A3 (cs) 1999-06-16
TR199900013T2 (xx) 1999-04-21
AU708882B2 (en) 1999-08-12
CA2260057A1 (en) 1998-01-15
KR20000023644A (ko) 2000-04-25
AR008395A1 (es) 2000-01-19
IS4932A (is) 1998-12-23
PL331090A1 (en) 1999-06-21
WO1998001449A1 (en) 1998-01-15

Similar Documents

Publication Publication Date Title
ID19609A (id) Senyawa-senyawa heterosiklik
ID19403A (id) Senyawa-senyawa heterosiklik
ID16152A (id) Senyawa-senyawa triaril
ID15904A (id) Senyawa-senyawa tiofenopirimidina
BR9710352A (pt) Compostos piridilpirrole
EE200000321A (et) Uudsed ühendid
BR9707051A (pt) Composto
DE69716924D1 (de) Phosphonat-nukleotid-verbindungen
ID18685A (id) Senyawa trisiklik tersubstitusi
EE9800430A (et) Uued ühendid
BR9705635A (pt) Compostos
DK0923594T3 (da) Bromotiacumicinforbindelser
DE69709659D1 (de) Halopropargyl-einschlussverbindungen
EE9900012A (et) Uudsed ühendid
SE9702775D0 (sv) Novel compounds
SE9601599D0 (sv) Novel compounds
ID17103A (id) Senyawa-senyawa sulfonamida
SE9603300D0 (sv) Compounds
SE9600275D0 (sv) Compounds
SE9601787D0 (sv) New compounds
SE9603505D0 (sv) New compounds
SE9604785D0 (sv) New compounds
SE9604787D0 (sv) New compounds
SE9603470D0 (sv) New compounds
SE9604788D0 (sv) New compounds